Intersect ENT is a medical technology company that develops products for the treatment of ear, nose, and throat (ENT) diseases. The company's products include PROPEL and SINUVA, which are drug-eluting implants designed to treat chronic sinusitis. Intersect ENT's products are designed to improve surgical outcomes and reduce the need for additional surgical procedures. The company's products are marketed to ENT physicians in the United States and internationally.